Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity - 29/05/14
Doi : 10.1016/j.jaci.2013.12.1092
Mahboobeh Mahdavinia, MD, PhD a, Roderick G. Carter, BS a, Christopher J. Ocampo, MD, PhD a, Whitney Stevens, MD, PhD a, Atsushi Kato, PhD a, Bruce K. Tan, MD b, Robert C. Kern, MD b, David B. Conley, MD b, Rakesh Chandra, MD b, Kathryn E. Hulse, PhD a, Lydia A. Suh, MSc a, James E. Norton, MSc a, Anju T. Peters, MD a, Leslie C. Grammer, MD a, Lawrence B. Schwartz, MD, PhD c, Robert P. Schleimer, PhD a, b 
a Division of Allergy-Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill
b Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, Ill
c Division of Rheumatology, Allergy and Immunology, Department of Medicine, Virginia Commonwealth University, Richmond, Va
| This study was supported by the National Institutes of Health (grants R37 HL068546, R01 HL078860, R01 AI072570, and R21 HL113913) and the Ernest S. Bazley Trust. |
|
| Disclosure of potential conflict of interest: A. Kato has received research support from the National Institutes of Health (NIH). B. K. Tan has received research support from the NIH and the Trilogical Society-American College of Surgeons; has consultant arrangements with Acclarent, Inc; and has received travel support from the Foundation for Innovation, Education, and Research in Otorhinolaryngology. A. T. Peters has received payment for lectures from Baxter. L. C. Grammer has received research support from the NIH, the Food Allergy Network, and S&C Electric; has received travel support from the NIH; has received a grant from the Bazley Foundation; has consultant arrangements from Astellas Pharmaceuticals; is employed by Northwestern University and Northwestern Medical Faculty Foundation; has received payment for lectures from the American Academy of Allergy, Asthma & Immunology and Mount Sinai; and has received royalties from Lippincott, UpToDate, BMJ, and Elsevier. L. B. Schwartz is a member of the Board of Directors for the Clinical Immunology Society and the Asthma and Allergy Foundation of America; has consultant arrangements with Sanofi Aventis, Dyax, and ViroPharma; has received research support from CSL Behring, Dyax, and the Mastocytosis Society/MastoKids; has received royalties for licensing arrangements for tryptase assay, antitryptase and antichymase mAbs, and anti-basophil mAb from VCU Tech Transfer; and is associate editor of the Journal of Clinical Immunology. R. P. Schleimer has received research support from the NIH; has consultant arrangements with Intersect ENT, GlaxoSmithKline, Allakos, Aurasense, Merck, and BioMarck; and has stock/stock options in Allakos and Aurasense. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 133 - N° 6
P. 1759-1763 - juin 2014 Retour au numéro
Article précédent
- Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: A pilot study
- Jean-Pierre Allam, Eike Wuestenberg, Hendrik Wolf, Ludger Klimek, Elke Decot, Andreas Horn, Jörg Schnitker, Thomas Bieber, Natalija Novak
- Traffic-related air pollution is associated with airway hyperresponsiveness
- Byoung-Ju Kim, So-Yeon Lee, Ji-Won Kwon, Young-Ho Jung, Eun Lee, Song I. Yang, Hyung-Young Kim, Ju-Hee Seo, Hyo-Bin Kim, Hwan-Cheol Kim, Jong-Han Leem, Ho-Jang Kwon, Soo-Jong Hong
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?